E-LIB Suche - Ergebnisse für: Pouessel, D.

1

TROPHY-U-01, a phase II open-label study of sacituzumab gov..:

Loriot, Y. ; Petrylak, D.P. ; Rezazadeh Kalebasty, A....
Annals of Oncology. 35 (2024) 4 - p. 392-401 , 2024

Link: https://doi.org/10.1016/..

2

Pemigatinib for metastatic or surgically unresectable uroth..:

Necchi, A. ; Pouessel, D. ; Leibowitz, R....
Annals of Oncology. 35 (2024) 2 - p. 200-210 , 2024

Link: https://doi.org/10.1016/..

3

Oncological outcomes of patients with node positive disease..:

Marcq, G. ; Kassouf, W. ; Roumiguié, M....
European Urology. 83 (2023) - p. S228-S229 , 2023

Link: https://doi.org/10.1016/..

4

EE608 Cost Effectiveness Analysis of a Large (Foundation Me..:

Perrier, L ; Tredan, O ; Morelle, M...
Value in Health. 25 (2022) 12 - p. S175 , 2022

Link: https://doi.org/10.1016/..

5

P04.15 Radiomics features in prediction of pseudo-progressi..:

Glemarec, G ; Pouessel, D ; Mervoyer, A...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii21-ii21 , 2021

Link: https://doi.org/10.1093/..

6

Role of Consolidative Radiotherapy For Metastatic Urothelia..:

Aboudaram, A. ; Chaltiel, L. ; Graff, P....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e871-e872 , 2020

Link: https://doi.org/10.1016/..

7

OS4.4 Hypofractionated stereotactic radiotherapy and anti-P..:

Pouessel, D ; Mervoyer, A ; Larrieu-Ciron, D...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii10-iii11 , 2019

Link: https://doi.org/10.1093/..

8

FGFR3 mutations and their relation to FGFR3 expression and ..:

Mertens, L.S. ; Van Rhijn, B.W.G. ; Mayr, R....
European Urology Supplements. 18 (2019) 1 - p. e1450-e1451 , 2019

Link: https://doi.org/10.1016/..

9

P01.094Hypofractionnated Stereotactic Radiation Therapy and..:

Larrieu-Ciron, D ; Peyraga, G ; Pouessel, D...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii252-iii252 , 2018

Link: https://doi.org/10.1093/..

10

1591 Functional iron deficiency during the first-line chemo..:

Gauthier, H. ; Thery, L. ; Le Maignan, C....
European Journal of Cancer. 51 (2015) - p. S235 , 2015

Link: https://doi.org/10.1016/..

11

2859 A multicenter phase II of sunitinib in patients with l..:

De La Fouchardiere, C. ; Delord, J.P. ; Bazignan, A. Doussau De...
European Journal of Cancer. 51 (2015) - p. S576 , 2015

Link: https://doi.org/10.1016/..

12

Combined Chemoradiation Therapy With Gemcitabine and Cispla..:

Riou, O. ; Culine, S. ; Rebillard, X....
International Journal of Radiation Oncology*Biology*Physics. 84 (2012) 3 - p. S419 , 2012

Link: https://doi.org/10.1016/..

13

7021 POSTER Multidisciplinary Management of Castration Resi..:

de La Motte Rouge, T. ; Pouessel, D. ; Benchikh, A....
European Journal of Cancer. 47 (2011) - p. S490-S491 , 2011

Link: https://doi.org/10.1016/..

14

Assessing Long-term Treatment Benefits Using Complementary ..:

Cavillon, Ana ; Pouessel, Damien ; Houédé, Nadine...
European Urology. 85 (2024) 3 - p. 293-300 , 2024

Link: https://doi.org/10.1016/..

15

Derazantinib alone and with atezolizumab in metastatic urot..:

Necchi, Andrea ; Ramlau, Rodryg ; Falcón González, Alejandro...
JNCI Cancer Spectrum. 8 (2024) 3 - p. , 2024

Link: https://doi.org/10.1093/..